Canton Strategic Holdings (CNTN) EPS (Basic) (2021 - 2026)
Canton Strategic Holdings (CNTN) reported EPS (Basic) of -$0.23 for Q1 2026, up 76.77% on a YoY basis from -$0.13 in Q1 2025, and down 142.59% quarter-over-quarter from $0.54 in Q4 2025.
Canton Strategic Holdings (CNTN) EPS (Basic) (2021 - 2026) Analysis & Trends
Canton Strategic Holdings has reported EPS (Basic) for 6 years, with the latest figure at -$0.23 in Q1 2026.
- For the quarter ending Q1 2026, EPS (Basic) rose 76.77% year-over-year to -$0.23; the trailing twelve-month figure through Mar 2026 stood at -$0.67 (up 91.5% YoY), and the FY2025 full-year result was -$1.12, up 88.1% from the prior year.
- EPS (Basic) for Q1 2026 stood at -$0.23, down from $0.54 in the prior quarter.
- The five-year high for EPS (Basic) was $68.48 in Q4 2023, with the low at -$52.06 in Q2 2023.
- Historically, EPS (Basic) has averaged -$3.43 across 5 years, with a median of -$0.99 in 2025.
- The largest YoY upside for EPS (Basic) was 477.92% in 2023 against a maximum downside of 37285.71% in 2023.
- Canton Strategic Holdings' EPS (Basic) stood at -$18.12 in 2022, then jumped by 477.92% to $68.48 in 2023, then slumped by 102.95% to -$2.02 in 2024, then surged by 126.73% to $0.54 in 2025, then plunged by 142.59% to -$0.23 in 2026.
- The last three EPS (Basic) figures came in at -$0.23 (Q1 2026), $0.54 (Q4 2025), and -$0.34 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -0.68 |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 3.06 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 0.00 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 0.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 0.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 0.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 4.06 |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -0.06 |
| 10 | Canton Strategic Holdings | 699.97 Mn | 658.44 Mn | - | -0.23 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.23 |
| Dec 31, 2025 | 0.54 |
| Sep 30, 2025 | -0.34 |
| Jun 30, 2025 | -0.64 |
| Mar 31, 2025 | -0.99 |
| Dec 31, 2024 | -2.02 |
| Sep 30, 2024 | -2.45 |
| Jun 30, 2024 | -2.42 |
| Mar 31, 2024 | -2.55 |
| Dec 31, 2023 | 68.48 |
| Sep 30, 2023 | -39.42 |
| Jun 30, 2023 | -52.06 |
| Mar 31, 2023 | -5.84 |
| Dec 31, 2022 | -18.12 |
| Sep 30, 2022 | -0.18 |
| Jun 30, 2022 | 0.14 |
| Mar 31, 2022 | -0.28 |
| Dec 31, 2021 | 0.38 |
| Sep 30, 2021 | -0.13 |
| Jun 30, 2021 | -0.24 |